TP53 mutations were determined in surgically resected primary tumor samples from six patients with high stage (II-IV), moderate to poorly differentiated head and neck squamous cell carcinoma (HNSCC). The gene discussed is TP53; the disease is head and neck squamous cell carcinoma.